Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lyme disease
Lyme disease
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says
Reuters
Thu, 10/12/23 - 11:36 am
Pfizer
clinical trials
Lyme disease
Valneva
vaccines
FDA
Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response
Fierce Biotech
Thu, 09/7/23 - 09:37 am
Pfizer
Lyme disease
vaccines
pediatric
clinical trials
VLA15
Valneva
Pfizer cuts enrollment for Lyme disease trial after CRO debacle
Fierce Biotech
Tue, 08/22/23 - 11:32 pm
Pfizer
vaccines
clinical trials
Lyme disease
Valneva, Pfizer push back timeline for Lyme disease vaccine
BioPharma Dive
Thu, 05/4/23 - 08:53 pm
Pfizer
Valneva
vaccines
Lyme disease
Moderna announces new vaccine candidates against Lyme disease and norovirus
Biopharma Reporter
Wed, 04/12/23 - 12:02 pm
Moderna Therapeutics
MRNA
vaccines
Lyme disease
norovirus
Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025
Seeking Alpha
Sun, 03/26/23 - 11:12 pm
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
Pfizer, Valneva remove half of participants from study of Lyme disease shot
BioPharma Dive
Fri, 02/17/23 - 11:27 am
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
Pfizer-Valneva's Lyme vaccine triggers 6-month antibody response, validating phase 3 regimen
Fierce Biotech
Thu, 12/1/22 - 10:31 am
Pfizer
Valneva
Lyme disease
vaccines
clinical trials
VLA015
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
BioSpace
Tue, 08/9/22 - 06:27 am
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
Pfizer Buys Stake in Valneva to Advance Lyme Disease Vaccine
BioSpace
Mon, 06/20/22 - 10:32 am
Pfizer
vaccines
Valneva
Lyme disease
Valneva and Pfizer report positive Phase 2 data for Lyme disease vaccine in children
Biopharma Reporter
Tue, 04/26/22 - 10:27 am
Valneva
Pfizer
clinical trials
vaccines
VLA15
Lyme disease
pediatric
Pfizer's $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies
Fierce Biotech
Fri, 02/4/22 - 11:06 am
Pfizer
Valneva
vaccines
Lyme disease
clinical trials
VLA15
Research Roundup: A Potential Cause of Alzheimer’s Disease and More
BioSpace
Fri, 12/3/21 - 10:52 am
R&D
Alzheimer's disease
ALS
Lyme disease
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping
Fierce Biotech
Tue, 09/28/21 - 11:08 am
Valneva
Pfizer
Lyme disease
clinical trials
vaccines
VLA15
Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate
Biopharma Reporter
Mon, 03/8/21 - 09:14 pm
Pfizer
Valneva
clinical trials
Lyme disease
VLA15
Amid Covid-19 hunt, Pfizer adds Lyme disease vaccine in $308M deal with Valneva
Endpoints
Thu, 04/30/20 - 10:42 am
Pfizer
Lyme disease
vaccines
Valneva
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Forbes
Sat, 01/11/20 - 11:05 pm
Lyme disease
vaccines
Valneva
VLA015
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Stat
Fri, 08/23/19 - 10:13 am
Lyme disease
vaccines
drug development
LYMErix
VLA15
Valneva
First Two-Tiered Algorithm Snags FDA Clearance for Lyme Disease
RAPS.org
Tue, 07/30/19 - 04:22 pm
Lyme disease
diagnostics
FDA
Zeus
Long-term Antibiotic Use For Lyme Disease Doesn't Work, Study Finds
Forbes
Mon, 04/4/16 - 09:09 am
antiobiotics
Lyme disease